This is a multi centre, single arm, prospective observational phase 4 study in naive or pretreated patients with myopic neovascularization. The patients will be treated with intravitreal injections of Aflibercept following a real life protocol.

This sudy aims to evaluate the visual acuity during a 36 months period of time.

Inclusion Criteria:

• Man or woman aged 18 years and more under reliable method of contraception for woman with childbearing potenteial (hormonal or any intrauterine devices).

• High myopy defined by refractive error ≤ -6 D or History of high myopia among pseudophakic patient or patient treated with refractive surgery

• Patient with active CNVm

• • Patients naïve or Patients pretreated with previous history of laser photocoagulation or PDT or by other anti-VEGF treatments who did not receive injection since the last 3 month

  • with OCT or angiography examination

Exclusion Criteria:

• Treatment with an anti VEGF administrated by intravitreal injection within 1 months prior to baseline in the study eye.
• Treatment with PDT or laser administrated within 6 months prior to baseline in the study eye.
• History of vitrectomy in the study eye
• History of any other retinal disease
• VA less than 20/250

• Active mCNV among:
• Naïve patients.
• Patients with previous history of laser photocoagulation or PDT, with no history of anti-VEGF.
• Patients with previous history of other anti-VEGF treatments.including ranibizumab or bevacizumab, with sustaining mCNV activity, who did not receive injection since the last 3 month